Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ECTRIMS 2022

What's new?

View all
3:06
The timing and choice of DMTs for MS patients
Jaume Sastre-Garriga • 28 Oct 2022
4:00
Genetic analysis of MS severity identifies a novel locus
Adil Harroud • 27 Oct 2022
2:35
Imaging techniques to monitor remyelination in MS
Cristina Granziera • 28 Oct 2022
3:21
Emerging MS research: PIRA & prediction models
João José Cerqueira • 28 Oct 2022

Treatment updates

View all
1:12
Autologous hematopoietic stem cell transplantation for the treatment of MS
Riccardo Saccardi • 28 Oct 2022
1:08
Post-authorization safety study of teriflunomide in MS
Melinda Magyari • 28 Oct 2022
1:28
The benefits of immune reconstitution therapy in MS
Celia Oreja-Guevara • 28 Oct 2022
6:12
Population-based study on polypharmacy and multiple sclerosis
Anibal Chertcoff • 28 Oct 2022

Biology

View all
5:24
Characterizing the prodromal phase in multiple sclerosis
Helen Tremlett • 20 Oct 2022
2:03
The role of Epstein-Barr virus in the pathogenesis of MS
Hans Lassmann • 27 Oct 2022

Biomarkers

View all
2:15
Brain MRI vs. spinal cord MRI in measuring cervical spinal cord atrophy
Burcu Zeydan • 27 Oct 2022
2:05
The association between serum/CSF biomarkers and OCT measures in CIS patients
Angela Vidal-Jordana • 26 Oct 2022

NMOSD

View all
4:49
Comorbidities in MS and NMOSD
Helen Tremlett • 20 Oct 2022
2:26
Pregnancy planning: differences between counselling NMOSD and MS patients
Melinda Magyari • 28 Oct 2022
5:25
Current diagnostic and treatment measures for AQP4-IgG-positive NMOSD
Kazuo Fujihara • 28 Oct 2022
2:18
Predictors of early serologic diagnosis of AQ4-IgG positive NMOSD
Dalia Rotstein • 27 Oct 2022
The content of VJNeurology is intended for healthcare professionals